CoChat

Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis

Open access
Le Morvan de Sequeira, Charlotte, Hengstberger, Charlotte, Enck, Paul, Mack, Isabelle · 2022 · Nutrients

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Abstract

Background: The gut microbiota impacts on central nervous system (CNS) function via the microbiota–gut–brain axis. Thus, therapeutics targeting the gut microbiota such as probiotics have the potential for improving mental health. This meta-analysis synthesizes the evidence regarding the impacts of probiotics on psychological well-being, psychiatric symptoms and CNS functioning. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were applied for executing this review using the databases PubMed, Web of Science and Cochrane Library. The data were summarized at qualitative and quantitative level. Results: Fifty-four randomized placebo-controlled studies were included, of which 30 were eligible for meta-analysis. If investigated, the probiotics mostly exerted effects on CNS function. Most probiotics did not affect mood, stress, anxiety, depression and psychiatric distress when compared to placebo at the qualitative level. At quantitative level, depression and psychiatric distress improved slightly in the probiotic condition (depression: mean difference −0.37 (95% CI: −0.55, −0.20); p ≤ 0.0001; psychiatric distress: mean difference −0.33 (95% CI: −0.53, −0.13); p = 0.001). Conclusions: To date it is unclear to which extent and in which specific areas next generation probiotics selected and developed for their ability to improve psychiatric condition and potentially other CNS functions are promising.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu14030621

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PRISMA flow chart for study inclusion.
Figure 1 PRISMA flow chart for study inclusion.CC BY · PubMed Central
Figure 2 Study outcomes at qualitative level for the most used questionnaires compared between probiotic versus placebo intervention. ↔: no significant differences between the groups; ↑: improvement p < 0.05; ↑↑: improvement p < 0.01; ↑↑↑: improvement p < 0.001; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; DASS-42: Depression, Anxiety and Stress Scale; GHQ: General Health Questionnaire; HADS-A/-D: Hospital Anxiety and Depression Scale; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Depression Rating Scale; LEIDs: Leiden index of depression severity; POMS: Profile of Mood States; PSQI: Pittsburgh Sleep Quality Index; PSS: Perceived Stress Scale; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status; SCL90: Symptoms Checklist-90; STAI: State Trait Anxiety Inventory.
Figure 2 Study outcomes at qualitative level for the most used questionnaires compared between probiotic versus placebo intervention. ↔: no significant differences between the groups; ↑: improvement p < 0.05; ↑↑: improvement p < 0.01; ↑↑↑: improvement p < 0.001; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; DASS-42: Depression, Anxiety and Stress Scale; GHQ: General Health Questionnaire; HADS-A/-D: Hospital Anxiety and Depression Scale; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Depression Rating Scale; LEIDs: Leiden index of depression severity; POMS: Profile of Mood States; PSQI: Pittsburgh Sleep Quality Index; PSS: Perceived Stress Scale; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status; SCL90: Symptoms Checklist-90; STAI: State Trait Anxiety Inventory.CC BY · PubMed Central
Figure 3 Study outcomes at qualitative level for the studies included in the meta-analysis. Comparison between the probiotic and placebo group [20,30,32,33,37,38,41,42,44,45,46,47,48,49,51,52,55,57,58,63,64,66,67,68,69,70,71,72,77,78]. ↔: no significant differences between the groups; ↑: significant improvement in the probiotic group versus placebo p < 0.05; ↑↑: significant improvement in the probiotic group versus placebo p < 0.01.
Figure 3 Study outcomes at qualitative level for the studies included in the meta-analysis. Comparison between the probiotic and placebo group [20,30,32,33,37,38,41,42,44,45,46,47,48,49,51,52,55,57,58,63,64,66,67,68,69,70,71,72,77,78]. ↔: no significant differences between the groups; ↑: significant improvement in the probiotic group versus placebo p < 0.05; ↑↑: significant improvement in the probiotic group versus placebo p < 0.01.CC BY · PubMed Central
Figure 4 Quantitative analysis for Profile of Mood States (POMS) of randomized controlled trials receiving either probiotics or placebo treatment. Murata 2018 [54], Ohsawa 2018 [58], Sashihara 2013 [69], Shinkai 2013 [72].
Figure 4 Quantitative analysis for Profile of Mood States (POMS) of randomized controlled trials receiving either probiotics or placebo treatment. Murata 2018 [54], Ohsawa 2018 [58], Sashihara 2013 [69], Shinkai 2013 [72].CC BY · PubMed Central
Figure 5 Quantitative analysis for Perceived Stress scale (PSS) of randomized controlled trials receiving either probiotics or placebo treatment. Chung 2014 [36], Messaoudi 2011 [52], Östlund-Lagerström 2016 [59], Patterson 2020 [60], Sanchez 2017 [68].
Figure 5 Quantitative analysis for Perceived Stress scale (PSS) of randomized controlled trials receiving either probiotics or placebo treatment. Chung 2014 [36], Messaoudi 2011 [52], Östlund-Lagerström 2016 [59], Patterson 2020 [60], Sanchez 2017 [68].CC BY · PubMed Central
Figure 6 Quantitative analysis for anxiety of randomized controlled trials receiving either probiotics or placebo treatment. Eskandarzadeh 2021 [30], Gualtieri 2020 [42], Ho 2021 [43], Karbownik 2020 [46], Kato-Kataoka 2016 [47], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Patterson 2020 [60], Raygan 2018 [62], Raygan 2019 [63], Roman 2018 [65], Sanchez 2017 [68], Steenbergen 2015 [73], Takada 2016 [74], Takada 2017 [75], Tran 2019 [76].
Figure 6 Quantitative analysis for anxiety of randomized controlled trials receiving either probiotics or placebo treatment. Eskandarzadeh 2021 [30], Gualtieri 2020 [42], Ho 2021 [43], Karbownik 2020 [46], Kato-Kataoka 2016 [47], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Patterson 2020 [60], Raygan 2018 [62], Raygan 2019 [63], Roman 2018 [65], Sanchez 2017 [68], Steenbergen 2015 [73], Takada 2016 [74], Takada 2017 [75], Tran 2019 [76].CC BY · PubMed Central
Figure 7 Quantitative analysis for depression of randomized controlled trials receiving either probiotics or placebo treatment. Akkasheh 2016 [32], Ho 2021 [43], Kazemi 2019 [48], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Papalini 2019 [20], Raygan 2018 [62], Raygan 2019 [63], Reininghaus 2020 [64], Roman 2018 [65], Rudzki 2019 [67], Sanchez 2017 [68], Steenbergen 2015 [73], Zhang 2021 [79].
Figure 7 Quantitative analysis for depression of randomized controlled trials receiving either probiotics or placebo treatment. Akkasheh 2016 [32], Ho 2021 [43], Kazemi 2019 [48], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Papalini 2019 [20], Raygan 2018 [62], Raygan 2019 [63], Reininghaus 2020 [64], Roman 2018 [65], Rudzki 2019 [67], Sanchez 2017 [68], Steenbergen 2015 [73], Zhang 2021 [79].CC BY · PubMed Central
Figure 8 Overview of psychiatric distress symptom outcomes according to questionnaire. Gualtieri 2020 [42], Messaoudi 2011 [52], Mohammadi 2016 [53], Nishida 2019 [56], Nishihira 2014 [57], Raygan 2018 [62], Reininghaus2020 [64], Rudzki 2019 [67].
Figure 8 Overview of psychiatric distress symptom outcomes according to questionnaire. Gualtieri 2020 [42], Messaoudi 2011 [52], Mohammadi 2016 [53], Nishida 2019 [56], Nishihira 2014 [57], Raygan 2018 [62], Reininghaus2020 [64], Rudzki 2019 [67].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 82 references

Research works printed but not linked: 1

  1. (Review Manager (RevMan), 2020). Review Manager (RevMan), Version 5.4.

Cited by

See all 101

Metadata

Authors
Le Morvan de Sequeira, C., Hengstberger, C., Enck, P., & Mack, I.
Affiliations
  • Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, 72076 Tübingen, Germany
  • Universitätsklinikum Tübingen (DE)
Corresponding author
Mack, Isabelle
Venue
Nutrients
Publisher
MDPI AG
Published
2022-01-30
Volume
14
Issue
3
Pages
621
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4210634251
Cited by
82
References
82
Citations by year
2026: 15 · 2025: 18 · 2024: 18 · 2023: 20 · 2022: 10
FWCI
1.51
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • German Aerospace Center (50WB1920)
  • Open Access Publishing Fund of Tübingen University (not applicable)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
probiotics, gut microbiota, microbiota-gut-brain axis, psychiatric symptoms, depression, anxiety, stress, psychiatric distress, mood, central nervous system function, mental health
MeSH terms
Gastrointestinal Microbiome, Anxiety Disorders, Central Nervous System, Depression, Humans, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.3390/nu14030621
The paper
Le Morvan de Sequeira, C., Hengstberger, C., Enck, P., & Mack, I. (2022). Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis. Nutrients. https://doi.org/10.3390/nu14030621

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.